Minireviews
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3546-3562
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3546
Figure 2
Figure 2 Possibly cost-effective approaches for identifying asymptomatic individuals with a high risk of gastric cancer development. 1The age-standardized incidence rate is greater than 20 per 100000. 2Applying selective screening for subjects with high-risk pre-endoscopic features. 3Not yet shown to reduce gastric cancer mortality. 4The performance of serum PG I/II ratio should be locally validated. 5Cost-effectiveness should be considered based on the local age-standardized incidence and the cost of esophagogastroduodenoscopy. In multi-ethnic populations, ethnicity-based screening for high-risk ethnic groups should be considered. EGD: Esophagogastroduodenoscopy; UGS: Upper gastrointestinal series; sPGr: Serum PG I/II ratio.